×
About 2,213 results

ALLMedicine™ Heparin-induced Thrombocytopenia Center

Research & Reviews  757 results

Case Report: Heparin-Induced Thrombocytopenia Treated With Plasmapheresis Before Living...
https://doi.org/10.1016/j.transproceed.2021.11.012
Transplantation Proceedings; Motokazu M, Kanae K et. al.

Jan 7th, 2022 - Heparin-induced thrombocytopenia (HIT) is a serious adverse effect of heparin. Additionally, although heparin can affect kidney transplantation, there only have been a few reports on this condition. Here, we report a case wherein surgery was safel...

Near fatal stent thrombosis in an aneurysmatic RCX as first manifestation of heparin in...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720211
BMC Cardiovascular Disorders; Zoller M, Atmowihardjo I et. al.

Jan 2nd, 2022 - Thrombosis resulting from heparin-induced thrombocytopenia (HIT) occurs in about 2% of patients without a significant decrease in platelet counts. We report on such a near fatal thrombotic event caused by coronary intervention. A supposedly "compl...

Management of Heparin-Induced Thrombocytopenia Using Plasmapharesis in Patients Undergo...
https://doi.org/10.1097/MAT.0000000000001631
ASAIO Journal (American Society for Artificial Internal O... Naqvi SY, Jawaid A et. al.

Dec 31st, 2021 - Heparin-induced thrombocytopenia (HIT) type-2 is a rare, but life-threatening complication that presents a unique challenge in patients undergoing cardiac surgery. Patients that require cardiac surgery with HIT present a dilemma between intraopera...

Cardiac transplantation after heparin-induced thrombocytopenia: A systematic review.
https://doi.org/10.1111/ctr.14567
Clinical Transplantation; Jimenez DC, Warner ED et. al.

Dec 21st, 2021 - Heparin-induced thrombocytopenia (HIT) presents a unique challenge in patients requiring orthotopic heart transplantation (OHT). We sought to pool the existing evidence in a systematic review. Electronic search was performed to identify all releva...

Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflam...
https://doi.org/10.1016/j.autrev.2021.103016
Autoimmunity Reviews; Chalayer E, Gramont B et. al.

Dec 17th, 2021 - Systemic autoimmune and inflammatory diseases have a complex and only partially known pathophysiology with various abnormalities involving all the components of the immune system. Among these components, antibodies, and especially autoantibodies a...

see more →

Guidelines  2 results

American Society of Hematology 2018 guidelines for management of venous thromboembolism...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258919
Blood Advances; Cuker A, Arepally GM et. al.

Nov 30th, 2018 - Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated by platelet-activating antibodies that target complexes of platelet factor 4 and heparin. Patients are at markedly increased risk of thromboembolism. These evidence-based ...

Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest...
https://doi.org/10.1378/chest.08-0677
Chest Warkentin TE, Greinacher A et. al.

Jul 24th, 2008 - This chapter about the recognition, treatment, and prevention of heparin-induced thrombocytopenia (HIT) is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th E...

see more →

Drugs  45 results see all →

Clinicaltrials.gov  16 results

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to Evaluate Safety and Efficacy of Danaparoid vs Argatroban
https://clinicaltrials.gov/ct2/show/NCT03809481

Feb 15th, 2021 - Objectives: Primary: To show that for the treatment of subjects with acute heparin-induced thrombocytopenia (HIT) danaparoid use is not inferior to argatroban in terms of efficacy. The primary efficacy endpoint (composite endpoint) is defined as t...

Pregnancy and Risk of Venous Thromboembolism
https://clinicaltrials.gov/ct2/show/NCT03659708

Jan 26th, 2021 - The management of venous thromboembolism (VTE) risk in pregnancy still remains a challenge. An individual assessment of the VTE risk is crucial for optimal thromboprophylaxis, but there is no validated tool to help clinicians stratify the risk in ...

Effect of LMWH on Pregnancy Outcome in Women With Multiple Failures of IVF-ET
https://clinicaltrials.gov/ct2/show/NCT03701750

Jul 29th, 2020 - Implantation failure seems to be inevitable in some couples undergoing IVF-ET treatment, despite transferred with high-quality embryos. There are several factors, including coagulation, are supposed to contribute to the implantation failure. Sever...

Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia
https://clinicaltrials.gov/ct2/show/NCT03269019

Aug 31st, 2017 - Heparin induced thrombocytopenia (HIT) is a kind of catastrophic thrombotic complications after the application of heparin. If HIT without treatment, death rate is as high as 30% to 50%. Early diagnosis of HIT and prevention of thrombosis is very ...

Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux
https://clinicaltrials.gov/ct2/show/NCT00378027

Jan 27th, 2017 - The current standard therapy for Acute Pulmonary Embolism (APE) involves admitting patients to the hospital for administration of parenteral anticoagulation therapy(Unfractionated Heparin, Low Molecular Weight Heparin, or Fondaparinux) as a bridge...

see more →

News  63 results

Organs From Deceased Recipients of AstraZeneca COVID-19 Vaccine May Pose Problems
https://www.medscape.com/viewarticle/955225

Jul 23rd, 2021 - NEW YORK (Reuters Health) - Organs from deceased donors who had received AstraZeneca's ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 may possibly prompt vaccine-induced thrombosis and thrombocytopenia (VITT) in recipients, according to a new study. A...

Thrombosis With Thrombocytopenia After mRNA COVID-19 Vaccine
https://www.medscape.com/viewarticle/953901

Jun 28th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. What is believed to be the first case of thrombosis with thrombocytopenia after a messenger RNA COVID-19 vaccine has been reported. The case repor...

Case Series Offers Solution for Post-COVID Vax Clotting?
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/93017

Jun 9th, 2021 - Intravenous immune globulin (IVIG) helped resolve the effects of vaccine-induced thrombotic thrombocytopenia (VITT) in three patients following receipt of the AstraZeneca COVID-19 vaccine, a case series in Canada found. Following administration of...

Post-Vax Clot Case Supports Angiomax Use
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/92419?trw=no

May 4th, 2021 - Bivalirudin (Angiomax) worked for one of the very rare cases of blood clots with low platelets after vaccination against COVID-19, researchers reported. The 40-year-old woman presented with a headache on the same day that the CDC and FDA hit pause...

COVID Vax Opponents and Rigid Proponents...Are Both Anti-Science?
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/92413

May 4th, 2021 - In mid-April, vaccine scientists and regulators were alerted to six serious adverse events after administration of the Johnson & Johnson COVID-19 vaccine. These events occurred in women ages 18 to 48 who had received the vaccine under emergency us...

see more →

Patient Education  2 results see all →